Treatment options for mild-to-moderate COVID-19 are becoming increasingly well established. A systematic review and network meta-analysis published in The BMJ evaluated 40 treatments across 187 ...

Laura holds a Master's in Experimental Neuroscience and a Bachelor's in Biology from Imperial College London. Her areas of expertise include health, medicine, psychology, and neuroscience. Laura holds ...

“The results of this study,” Dr. Gandhi concluded, “support the recommendations to use one of the following four medications for non-hospitalized patients with COVID-19 who are at high risk [of] ...

EARLY IN THE Covid pandemic, some medicines got reputations for potentially being able to treat the virus, even in the absence of evidence. While there are now scientifically-proven drugs used to ...

Individuals with compromised immunity and persistent COVID-19 infections can harbor drug-resistant variants of the SARS-CoV-2 virus, which have the potential to spread to the general population found ...

It wasn’t that long ago that people considered Moderna and Pfizer to be saviors. Their work during the COVID-19 pandemic brought on an unusual outpouring of support and goodwill toward the ...